Skip to main content

Table 3 Comorbidities and treatment of severe thrombocytopenic neonates in the three subgroups [n(%)]

From: Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study

Variables

No bleeding

(n = 52)

Minor bleeding

(n = 58)

Major bleeding

(n = 60)

PDA

19(36.5)

22(37.9)

37(61.7)

BPD

3(5.8)

4(6.9)

5(8.3)

NRDS

7(13.5)

8(13.8)

18(30.0)

Shock

5(9.6)

15(25.9)

20(33.3)

Coagulation disorders

16(30.8)

29(50.0)

40(66.7)

Sepsis

31(59.6)

37(63.8)

32(53.3)

NEC

8(15.4)

1(1.7)

8(13.3)

Mechanical ventilation

11(21.2)

22(37.9)

33(55.0)

PT

10(19.2)

25(43.1)

22(36.7)

  1. PDA Patent ductus arteriosus, BPD Bronchopulmonary dysplasia, NRDS Neonatal respiratory distress syndrome, NEC Necrotizing enterocolitis, PT Platelet transfusion